Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $389
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $389 Moomoo
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $389 Moomoo
Summary aggregated from Moomoo's public RSS feed. The full reporting belongs to Moomoo — please read it on their site.